Evidence-graded · Source-cited Peer-reviewer panel · 6 clinicians
PeptideVox

Androgenetic Alopecia

Androgenetic Alopecia is a recurring topic in our peptide coverage. This hub collects every article tagged Androgenetic Alopecia, newest first, each evidence-graded and tied to real, verifiable sources.

Skin, Hair & Aesthetic

Best Peptides for Thinning Hair & Density: Evidence Ranked

An evidence-graded ranking of the peptides marketed for hair thinning, density, and shedding — separating the modest human topical data from the mechanistic and mouse-only hype.

Skin, Hair & Aesthetic

Best Peptides for Hair Loss: 2026 Evidence Review

An evidence-graded ranking of the peptides marketed for androgenetic alopecia — zinc-thymulin, biotinoyl tripeptide-1/Procapil, GHK-Cu copper peptide, and PTD-DBM — separating the small human data from mouse work, blends, and marketing.

Skin, Hair & Aesthetic

Peptides for Hair Growth: Evidence, Grades & Safety

A clinical, evidence-first ranking of the peptides marketed for hair regrowth — zinc-thymulin, copper peptides, biotinoyl tripeptide-1 (Procapil) and PTD-DBM — graded honestly, with human versus preclinical evidence kept strictly separate.

Peptide Encyclopedia

Zinc-Thymulin: Evidence, Mechanism, Dosing & Legal Status

A clinical monograph on zinc-thymulin — the zinc-dependent thymic nonapeptide marketed as a topical hair-growth peptide. One small open-label human trial, solid zinc-biomarker biology, no RCT, and an unsettled 2026 legal status.

Peptide Encyclopedia

PTD-DBM: Evidence, Mechanism, Dosing & Legal Status

A clinical monograph on PTD-DBM — the CXXC5-Dishevelled disrupting peptide engineered to reactivate Wnt/β-catenin signaling for hair regrowth. Strong target biology, mouse-only efficacy, and no human trials.

Peptide Encyclopedia

Biotinoyl Tripeptide-1 (Biotinyl-GHK) for Hair: Evidence & Safety

A clinical monograph on Biotinoyl Tripeptide-1 — the biotinylated GHK matrikine peptide behind Procapil. Modest, consistent hair-density benefits in combination formulations, but no isolated-molecule human trial.

Frequently asked

What is Androgenetic Alopecia?

Androgenetic Alopecia is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.

How often is the Androgenetic Alopecia hub updated?

This hub updates automatically whenever a new article is tagged Androgenetic Alopecia, so the latest coverage appears first.

Are Androgenetic Alopecia claims sourced?

Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.

Medical Disclaimer · Read in full

PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.

01 · Not FDA-approved

The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.

02 · Research chemicals

Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.

03 · WADA-prohibited

Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.

04 · Consult a clinician

Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.

This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.